Abstract

Surgery in treatment of small cell lung cancer (SCLC) was abandoned by many in the 1970’s because only about 7% were resectable [l] and because the vast majority of the patients died from recurrent and disseminated disease in spite of resection. Combination chemotherapy has improved the outlook for patients with SCLC, but long-term survival is still obtained in less than 10% of the patients [2]. The most important determinant of longevity is extent of disease at time of diagnosis. Less than 2% of patients with extensive disease become long survivors. Among the 4045% of the patients, who have limited disease, a ‘normal’ mediastinum at pretreatment staging is a significant, good prognostic sign [3]. Data from very select series of resected patients similarly reflect an influence of disease extent, usually categorized by the TNM-system. The pTNM thus refers to the sum of peroperative, and pathological findings. Preoperative, clinical attributes, resulting in the cTNMstage, are not associated with a similar differentiated influence on the prognosis - especially because the nodal status (N, and NJ) is important, but difficult to verify in detail without thoracotomy [4,5]. The cTNM includes information on operability and it is well defined in operated as well as non-operated patients. A treatment policy of surgery therefore has to rely on the cTNM. The pTNM may have similar importance for treatment options available after surgery - but pTNM characteristics cannot facilitate comparison of results from surgical and ‘non-surgical’ series. Surgery in SCLC is optional in the few primarily operable patients as well as in patients, who are potentially resectable after combination chemotherapy. In the Copenhagen group we made a retrospective investigation of the outcome of surgery followed by chemotherapy in a series of 874 consecutive patients [6,7]. Sixty-eight patients, in whom the diagnosis of SCLC was obtained at an explorative thoracotomy, were excluded. Among the residual

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.